Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
doi 10.24294/ti.v2.i2.930
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EnPress Publisher

Related search

P3.01-04 Immune Checkpoint Inhibitors (ICIs) in NSCLC: Immune Related Adverse Events (irAEs) and Outcomes. A Canadian Single Institution Experience

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?

Oncologist
Cancer ResearchMedicineOncology
2019English

Immune Checkpoint Inhibitors in Melanoma: Review and Update

Journal of the Portuguese Society of Dermatology and Venereology
2018English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Survival Outcomes Following Combination Radiotherapy and Immune Checkpoint Inhibitors

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Update on Immune Checkpoint Inhibitors in Gynecological Cancers

Journal of Gynecologic Oncology
MedicineGynecologyOncologyObstetrics
2017English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

3) Immune Checkpoint Inhibitors for Gastrointestinal Tract Cancers

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

2) Lung Cancer Treatment Using Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy